comprehensive -WSS

comprehensive

author：fashion 2025-08-25 07:28:42 - browse：52261

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke.

He is also trying to fight the long legacy of racism in neuroscience. During 2020, when it was difficult to conduct research, he said, “I got the chance and the ability to read more widely and to just look into the legacy of neuroscience.” He found a direct line from racist pseudoscience like phrenology to disparities in neuroscience today, like how the texture of Black people’s hair can sometimes exclude them from clinical trials because electrodes are not designed for them. In 2021, he co-founded Black in Neuro, an organization dedicated to improving Black representation in neuroscience.

On this episode of the “First Opinion Podcast,” I spoke to him about how the past and present racism in neuroscience could be reflected in the future, especially as neurotechnology like brain implants become more common.

“I’m not saying that whatever electrode that you made or created is racist. But when you have someone who … creates a technology but doesn’t think about the wide range of users that are potentially going to use it, then that’s where the problem comes in,” he told me.

We also discussed the way inequities in neuroscience research are visible in stroke wards, how brain implants might jump from helping disabled people to being used for human enhancement, and more.

Our conversation was inspired by his recent First Opinion essay, “Neuroscience has to grapple with a long legacy of racism if it wants to move into the future.” The book I mention at the end is “Lock In” by John Scalzi, a great sci-fi mystery exploring themes of race, socioeconomic status, neurotechnology, and more.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

Previous article： The high cost of giving birth even with insurance
Next article： Google says AlphaFold 3 can map a vast universe of biomolecules

WSS

H5N1 communication has been strictly for the birds

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

In search for therapies for solid tumors, companies turn to claudin

FDA does about

Kenai launches with $82 million for Parkinson’s stem cell therapy

hotspot

comprehensive

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

focus

Medical records are filled with copy

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

In age of alternative facts, a scholarly course on calling out crap

RSV vaccines may be linked to small increased risk of developing GBS

United colonoscopy coverage change 'may cost lives,' doctors say

Elevance, private equity launch primary care company

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Study: Adult vaccinations pay for themselves in societal benefits

The high cost of giving birth even with insurance

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

entertainment

ALS groups 'won't be played again' by the FDA, drug sponsors

Medical device lobby: We're tired of waiting on Medicare coverage

Dairy farmers resist CDC push for PPE against bird flu virus

Study: Adult vaccinations pay for themselves in societal benefits

Elevance, private equity launch primary care company

Kenai launches with $82 million for Parkinson’s stem cell therapy

hotspot

explore

focus

focus